Comments on “Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics”

Yazan Ranneh; Ayman M. Mahmoud; Abdulmannan Fadel; Mohd Fadzelly Abu Bakar; Abdah Md Akim

doi:10.3389/fphar.2023.1228359

Comments on “Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics”

Yazan Ranneh
, Ayman M. Mahmoud
, Abdulmannan Fadel
, Mohd Fadzelly Abu Bakar
, Abdah Md Akim

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Article number	1228359
Journal	Frontiers in Pharmacology
Volume	14
DOIs	https://doi.org/10.3389/fphar.2023.1228359
Publication status	Published - 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Bifidobacterium
lipopolysaccharide
lipopolysaccharide binding protein
obesity
serum

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.3389/fphar.2023.1228359

Cite this

Comments on “Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics”. / Ranneh, Yazan; Mahmoud, Ayman M.; Fadel, Abdulmannan et al.
In: Frontiers in Pharmacology, Vol. 14, 1228359, 2023.

Research output: Contribution to journal › Comment/debate › peer-review

@article{2b753ecb6b7641479969ff1f255f23da,

title = "Comments on “Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics”",

keywords = "Bifidobacterium, lipopolysaccharide, lipopolysaccharide binding protein, obesity, serum",

author = "Yazan Ranneh and Mahmoud, \{Ayman M.\} and Abdulmannan Fadel and \{Abu Bakar\}, \{Mohd Fadzelly\} and \{Md Akim\}, Abdah",

year = "2023",

doi = "10.3389/fphar.2023.1228359",

language = "English",

volume = "14",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Comments on “Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics”

AU - Ranneh, Yazan

AU - Mahmoud, Ayman M.

AU - Fadel, Abdulmannan

AU - Abu Bakar, Mohd Fadzelly

AU - Md Akim, Abdah

PY - 2023

Y1 - 2023

KW - Bifidobacterium

KW - lipopolysaccharide

KW - lipopolysaccharide binding protein

KW - obesity

KW - serum

UR - https://www.scopus.com/pages/publications/85169551795

UR - https://www.scopus.com/pages/publications/85169551795#tab=citedBy

U2 - 10.3389/fphar.2023.1228359

DO - 10.3389/fphar.2023.1228359

M3 - Comment/debate

AN - SCOPUS:85169551795

SN - 1663-9812

VL - 14

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

M1 - 1228359

ER -

Comments on “Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics”

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this